(Q39755348)

14 September 2017

title

Heparan sulfate mediates amyloid-beta internalization and cytotoxicity (English)

1 reference

14 September 2017

0 references

4

Ulf Lindahl

1 reference

14 September 2017

5

Lars Lannfelt

1 reference

14 September 2017

Elina Sandwall

1

1 reference

14 September 2017

Paul O'Callaghan

series ordinal

2

1 reference

14 September 2017

Xiao Zhang

series ordinal

3

1 reference

14 September 2017

Jin-Ping Li

series ordinal

6

1 reference

14 September 2017

publication date

5 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

20

1 reference

14 September 2017

issue

5

1 reference

14 September 2017

page(s)

533-541

1 reference

Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-beta in vitro.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Heparan sulphate proteoglycans fine-tune mammalian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Intraneuronal Abeta42 accumulation in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

PrPSc incorporation to cells requires endogenous glycosaminoglycan expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Interactions between heparan sulfate and proteins-design and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Domain structure of heparan sulfates from bovine organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

The beta-amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

The role of heparan sulphate in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Molecular structure of heparan sulfate from Spalax. Implications of heparanase and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Cerebral amyloid angiopathy and its relationship to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate beta-amyloid(25-35) induced neurodegeneration in cultured hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWP205

21 January 2018

Identifiers

DOI

10.1093/GLYCOB/CWP205

1 reference

14 September 2017

1 reference